Methocarbamol
31 NDCs across 11 manufacturers|31 Generic,0 Brand
Methocarbamol is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $36 million on Methocarbamol across 3.2 million claims for 1.3 million beneficiaries.
Methocarbamol is available as 31 NDCs from 11 manufacturers (31 generic, 0 brand), with NADAC prices from $0.04 to $8.35 per EA — the most expensive product costs about 212× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
31
31G / 0B
Manufacturers
11
competing in market
Price Spread
$0.04 – $8.35
per EA
7d Activity
avg +0.6% WoW · of 31 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Oxford Pharmaceuticals, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Muscle Relaxant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing METHOCARBAMOL
Frequently Asked Questions
What is Methocarbamol used to treat?
Methocarbamol is used to treat muscle cramp, muscle rigidity, myositis, pain, spasm and tetanus, per the National Library of Medicine's MED-RT classification.
When did Methocarbamol become available as a generic?
FDA approved the first generic Methocarbamol (ANDA) on Jan 1, 1982. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Methocarbamol?
In 2024, Medicare Part D spent $36 million on Methocarbamol across 3.2 million claims for 1.3 million beneficiaries.
How many Methocarbamol products are on the market?
The Methocarbamol drug market contains 31 NDCs from 11 manufacturers — 31 generic and 0 brand products.
What is the price range for Methocarbamol?
NADAC reference prices for Methocarbamol range from $0.0395 to $8.3480 per EA — the most expensive product costs about 212× the cheapest.
Which manufacturers make Methocarbamol?
11 manufacturers list Methocarbamol in NADAC. Ranked by number of NDCs, the largest are Oxford Pharmaceuticals, LLC (6), Camber Pharmaceuticals Inc. (4), Solco Healthcare US LLC (4), Aurobindo Pharma Limited (4), Unichem Pharmaceuticals (USA) Inc. (4).
How has the price of Methocarbamol changed recently?
Over the past 7 days, 14 Methocarbamol NDCs rose and 14 fell, with a market-wide average change of +0.6%.